CD63-GPC1-Positive Exosomes Coupled with CA19-9 Offer Good Diagnostic Potential for Resectable Pancreatic Ductal Adenocarcinoma-Reference-Cited by-同舟云学术

CD63-GPC1-Positive Exosomes Coupled with CA19-9 Offer Good Diagnostic Potential for Resectable Pancreatic Ductal Adenocarcinoma

Published:2019-11 Issue:11 Volume:12 Page:1395-1403
ISSN:1936-5233
Container-title:Translational Oncology
language:en
Short-container-title:Translational Oncology

Author:

Buscail Etienne,Chauvet Alexandre,Quincy Pascaline,Degrandi Olivier,Buscail Camille,Lamrissi Isabelle,Moranvillier Isabelle,Caumont Charline,Verdon Severine,Brisson Alain,Marty Marion,Chiche Laurence,Laurent Christophe,Vendrely Veronique,Moreau-Gaudry François,Bedel Aurelie,Dabernat Sandrine

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference33 articles.

1. Cancer statistics, 2018;Siegel;CA Cancer J Clin,2018

2. Commentary: Pancreatic cancer: is the worst to come?;Buscail;Int J Epidemiol,2017

3. Endoscopic ultrasound-guided techniques for diagnosing pancreatic mass lesions: Can we do better?;Storm;World J Gastroenterol,2016

4. Imaging modalities for characterising focal pancreatic lesions;Best;Cochrane Database Syst Rev,2017

5. The prognostic role of time to diagnosis and presenting symptoms in patients with pancreatic cancer;Gobbi;Cancer Epidemiol,2013

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnostic plasma small extracellular vesicles miRNA signatures for pancreatic cancer using machine learning methods;Translational Oncology;2024-02

2. Glypican-1 may be a plasma biomarker for predicting the rupture of small intracranial aneurysms.;Journal of Proteomics;2024-02

3. The Diagnostic and Prognostic Value of Plasmatic Exosome Count in Cancer Patients and in Patients with Other Pathologies;International Journal of Molecular Sciences;2024-01-15

4. Extracellular Vesicular Analysis of Glypican 1 mRNA and Protein for Pancreatic Cancer Diagnosis and Prognosis;Advanced Science;2024-01-10

5. Towards the Clinical Implementation of Extracellular Vesicle-Based Biomarker Assays for Cancer;Clinical Chemistry;2024-01